SIAP
GWPH

Sterling Investment Advisors (Pennsylvania)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40
Closed -$9K – 589
2021
Q1 		$9K Hold
40
– – ﹤0.01% 415
2020
Q4 		$5K Hold
40
– – ﹤0.01% 408
2020
Q3 		$4K Hold
40
– – ﹤0.01% 398
2020
Q2 		$4K Hold
40
– – ﹤0.01% 393
2020
Q1 		$3K Hold
40
– – ﹤0.01% 367
2019
Q4 		$4K Sell
40
-50
-56% -$5.61K ﹤0.01% 376
2019
Q3 		$10K Sell
90
-100
-53% -$15.2K 0.01% 346
2019
Q2 		$33K Hold
190
– – 0.02% 252
2019
Q1 		$32K Hold
190
– – 0.02% 252
2018
Q4 		$18K Hold
190
– – 0.01% 288
2018
Q3 		$33K Hold
190
– – 0.02% 268
2018
Q2 		$26K Buy
190
+50
+36% +$7.1K 0.02% 270
2018
Q1 		$16K Hold
140
– – 0.01% 296
2017
Q4 		$18K Buy
140
+100
+250% +$11.8K 0.01% 268
2017
Q3 		$4K Hold
40
– – ﹤0.01% 319
2017
Q2 		$4K Hold
40
– – ﹤0.01% 341
2017
Q1 		$5K Hold
40
– – ﹤0.01% 305
2016
Q4 		$4K Buy
+40
New +$4.82K ﹤0.01% 281

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s GWPH Position: Q2 2021 in Review

Sterling Investment Advisors (Pennsylvania) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 40 shares — an estimated $9K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in GWPH in Q4 2016 and held it in 18 quarters. The position peaked at $33K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 40 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $9K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 18 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $33K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2021, filed 29 Jul 2021.